Myopathy Clinical Trial
Official title:
Repeated Bout Effect i Neuromuscular Diseases
The repeated bout effect (RBE) refers to the adaptation whereby a single bout of eccentric exercise protects against muscle damage from subsequent eccentric bouts. This effect has been shown in many muscle groups using both serum biomarkers, muscle soreness and imaging techniques. Though the effect is well described in healthy, it has never been studied in patients with neuromuscular diseases (NMDs). In healthy, the RBE is only described using eccentric exercise, but unlike healthy persons, patients with NMDs can experience significant muscle damage with concentric exercise. This raises the question, if patients with NMDs could also show RBE when performing concentric exercise.
The repeated bout effect (RBE) refers to the adaptation whereby a single bout of eccentric exercise protects against muscle damage from subsequent eccentric bouts. This effect has been shown in many muscle groups using both serum biomarkers, muscle soreness and imaging techniques. Though the effect is well described in healthy, it has never been studied in patients with neuromuscular diseases (NMDs). NMDs are a common term for diseases that affect the muscles by disease processes in the motor neuron, peripheral nerve, neuromuscular junction or the muscles. The diseases can cause symptoms such as muscle weakness, muscle fatigue and sometimes muscle pain and varying degrees of physical disability. As the mechanisms for disease varies among NMDs, it is likely that some patients will experience RBE in a similar fashion to healthy, while others may not. Recent years have shown significant breakthrough in the treatment development for various NMDs, and many of these treatments are currently or will soon be evaluated in clinical trials. As many trials will use exercise to evaluate treatment effect, it is vital to understand whether a single bout of exercise in itself provides a protective effect on the muscles of patients with NMDs. In healthy, the RBE is only described using eccentric exercise, but unlike healthy persons, patients with NMDs can experience significant muscle damage with concentric exercise. This raises the question, if patients with NMDs could also show RBE when performing concentric exercise. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06374719 -
WiTNNess - TNNT1 Myopathy Natural History Study
|
||
Not yet recruiting |
NCT03633565 -
Comparative Study of Strategies for Management of Duchenne Myopathy (DM)
|
Phase 4 | |
Enrolling by invitation |
NCT02235220 -
Reduction of Masticatory Muscle Activity by Restoring Canine Guidance
|
N/A | |
Terminated |
NCT00278564 -
Stem Cell Transplantation in Idiopathic Inflammatory Myopathy Diseases
|
Phase 1 | |
Completed |
NCT01642056 -
EPI-743 for Metabolism or Mitochondrial Disorders
|
Phase 1/Phase 2 | |
Completed |
NCT02011282 -
Electro-Neuro-Muscular Stimulation in ICU
|
N/A | |
Completed |
NCT01702987 -
Evaluation of Ubiquinol on Mitochondrial Oxidative Capacity in Statin Patients Using 31PMRS
|
N/A | |
Active, not recruiting |
NCT01225614 -
Efficacy and Tolerance of Early Launching of Nocturnal Non Invasive
|
Phase 3 | |
Recruiting |
NCT03749538 -
Acute Transcranial Direct Current Stimulation in Patients With Systemic Autoimmune Myopathies
|
N/A | |
Completed |
NCT02442986 -
Neurological Outcome in Surgical and Non-surgical Septic Patients
|
N/A | |
Recruiting |
NCT01022450 -
Study of the Causes of the Breakdown of Muscle Fibers in Hospitalized Patients
|
N/A | |
Withdrawn |
NCT00990834 -
Muscle Characteristics Associated With Statin Therapy
|
N/A | |
Active, not recruiting |
NCT00937001 -
Critical Illness Myopathy as a Cause of Debilitating ICU-Acquired Weakness
|
N/A | |
Recruiting |
NCT01353430 -
Characterization of Inclusion Body Myopathy Associated With Paget's Disease of Bone and Frontotemporal Dementia (IBMPFD)
|
||
Completed |
NCT03751644 -
Peripherical Neuromuscular Electrical Stimulation in Systemic Autoimmune Myopathies
|
N/A | |
Completed |
NCT02765828 -
Identification of Tongue Involvement in Late-Onset Pompe Disease
|
||
Withdrawn |
NCT02124070 -
Therapeutic Effect of Recombinant Human Growth Hormone (rhGH) on the Myopathy of Cystinosis
|
Phase 1/Phase 2 | |
Completed |
NCT02706314 -
Impact of Human Blood Serum From Critically Ill Patients on Human Colon Neuronal Networks.
|
||
Recruiting |
NCT03042286 -
SAPhIRE Statin Adverse Drug Reaction
|
||
Not yet recruiting |
NCT04941079 -
Safety and Efficacy of Inactivated SARS-CoV-2 Vaccine in Immune-related Myopathy (Myasthenia Gravis and Inflammatory Myopathy) Patients :a Prospective Observational Study
|